Biogen BIIB EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biogen's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biogen's EBITDA margin?
- Biogen (BIIB) reported EBITDA margin of 27% in Q1 2026.
- How has Biogen's EBITDA margin changed year-over-year?
- Biogen's EBITDA margin increased by 0.5% year-over-year, from 26.9% to 27%.
- What is the long-term trend for Biogen's EBITDA margin?
- Over 5 years (2020 to 2025), Biogen's EBITDA margin has grown at a -8.0% compound annual growth rate (CAGR), from 39.7% to 26.2%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.